[ad_1]
According to KIRO-TV in Seattle (via Apple Insider), the Apple Watch Series 4 would once again rescue its owner. AFib had already been diagnosed in this unnamed man and his heart was beating normally. As a result, it was removed from the anticoagulants. Dr. Phil Massey, a cardiologist at Pacific Medical Centers in Seattle, said that the man had entered the office with his Apple Watch Series 4 and had shown the doctor the results of an ECG that he had recently taken with the device. Dr. Massey stated that he was in agreement with the watchmaking piece to say that AFib of the man had come back, and that he had been moving the patient back with anti coagulants. The cardiologist said the Apple Watch could save the life of this man. "… we gave him an anticoagulant to prevent strokes, so it's a big problem," he said.
Realizing how much a smart watch can really make the difference between life and death, the Doctor is optimistic about the future. He said: "I hope that other heart rhythm problems can be detected in the future outside of the doctor's office.And it is exciting."
If Google unveils this year's famous Pixel Watch, it could also offer an ECG monitor. Last month, we announced that the Verily Study Watch, used for research and prescription only, had recently been approved by the FDA for its ECG function. This is a big problem because Verily belongs to Google Alphabet. It would not be an exaggeration to believe that Google would transfer its monitor over the monitor.
The GPS version of the Apple Watch Series 4 starts at $ 399 at Apple. The GPS + cellular model is priced at $ 499 and up.
[ad_2]
Source link